આજના સમયમાં વજન ઘટાડવા માટે GLP-1 medicines વિશે ખૂબ ચર્ચા થઈ રહી છે. Semaglutide અને Tirzepatide જેવી દવાઓએ obesity અને weight managementના ક્ષેત્રમાં નવી સારવારની શક્યતાઓ ઊભી કરી છે. પરંતુ GLP-1 medicine માત્ર “વજન ઘટાડવાનું injection” નથી. આ દવાઓ યોગ્ય દર્દીઓમાં ભૂખ, ખાવાની માત્રા, blood sugar અને metabolic health સુધારવામાં મદદ કરી શકે છે અને…
Thinking of stopping Mounjaro or Ozempic after weight loss or improved diabetes control? Before you stop, it’s important to understand what may happen to your appetite, body weight, and blood sugar levels. In this blog, Dr. Moxit Shah, Endocrinologist in Ahmedabad, explains the possible effects of stopping semaglutide or tirzepatide, including weight regain, increased hunger, and worsening sugar control, and how to stop these medicines safely under expert guidance.
By Dr. Moxit Shah, Endocrinologist & Diabetes Specialist, Ahmedabad Introduction Weight loss medicines such as Mounjaro (tirzepatide), Ozempic (semaglutide), Wegovy, and other GLP-1 receptor agonists have revolutionized obesity treatment. These medications can help patients lose significant amounts of weight, improve blood sugar control, reduce fatty liver disease, and lower cardiovascular risk. However, like all medications,…
GLP-1 specialist in Ahmedabad: Dr. Moxit Shah provides medically supervised Weight Loss and Type 2 Diabetes treatment with appropriate GLP-1 therapies, including Semaglutide and Tirzepatide.
